| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11064-015-1757-0 |
| P698 | PubMed publication ID | 26547196 |
| P50 | author | Ryszard Brus | Q98288392 |
| Przemyslaw Nowak | Q62015555 | ||
| P2093 | author name string | Russell W Brown | |
| Richard M Kostrzewa | |||
| P2860 | cites work | Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects | Q22248075 |
| Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment | Q26781620 | ||
| RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway | Q27865228 | ||
| Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4) | Q28253496 | ||
| Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients | Q28302217 | ||
| Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood | Q33651050 | ||
| The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia | Q33679799 | ||
| The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia | Q34156147 | ||
| The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond | Q34455707 | ||
| 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding | Q34460119 | ||
| Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine | Q34692213 | ||
| Chronic intermittent ethanol exposure reduces presynaptic dopamine neurotransmission in the mouse nucleus accumbens. | Q35287737 | ||
| Dopamine D2 agonist priming in intact and dopamine-lesioned rats. | Q36003804 | ||
| Predictors of schizophrenia--a review | Q36157733 | ||
| Learning From Animal Models of Obsessive-Compulsive Disorder | Q36249163 | ||
| Signaling pathways in schizophrenia: emerging targets and therapeutic strategies | Q37767805 | ||
| Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model | Q38025028 | ||
| Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings | Q38124448 | ||
| Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia | Q38149953 | ||
| Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats | Q69897790 | ||
| Yohimbine both increases and decreases nociceptive thresholds in rats: Evaluation of the dose-response relationship | Q70150368 | ||
| The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity | Q70617298 | ||
| The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity | Q71232605 | ||
| A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration | Q71516528 | ||
| Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats | Q71539016 | ||
| Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole | Q71719881 | ||
| Low-dose quinpirole ontogenically sensitizes to quinpirole-induced yawning in rats | Q72212471 | ||
| Ontogenetic quinpirole treatment induces vertical jumping activity in rats | Q72655864 | ||
| 7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats | Q73289653 | ||
| Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpirole | Q73553405 | ||
| Patients with schizophrenia who smoke. Private disaster, public resource | Q73647188 | ||
| Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications | Q78166599 | ||
| Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation. | Q38292072 | ||
| Perinatal 6-Hydroxydopamine Modeling of ADHD. | Q38609428 | ||
| Drugs affecting dopamine neurons and yawning behavior | Q40114468 | ||
| Dopamine receptor supersensitivity | Q40538655 | ||
| Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpirole | Q41175305 | ||
| Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. | Q41490533 | ||
| RGS9 modulates dopamine signaling in the basal ganglia | Q42443389 | ||
| Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics | Q43135417 | ||
| Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes | Q43225886 | ||
| Is dopamine-agonist induced yawning behavior a D3 mediated event? | Q43479600 | ||
| Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment | Q43625348 | ||
| Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. | Q43979573 | ||
| Ontogenetic homologous sensitization to the antinociceptive action of quinpirole in rats | Q44238907 | ||
| Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia | Q44241333 | ||
| Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior | Q44423347 | ||
| Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. | Q44566861 | ||
| Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats | Q44722657 | ||
| Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression | Q44831655 | ||
| Neonatal quinpirole treatment impairs Morris water task performance in early postweanling rats: relationship to increases in corticosterone and decreases in neurotrophic factors | Q44991307 | ||
| The effects of eticlopride on Morris water task performance in male and female rats neonatally treated with quinpirole | Q45254522 | ||
| Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists. | Q46011226 | ||
| Nicotine sensitization in adult male and female rats quinpirole-primed as neonates | Q46544579 | ||
| The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole | Q46891193 | ||
| Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice | Q46915523 | ||
| Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex | Q46923633 | ||
| Hyperactivity in the offspring of nicotine-treated rats: role of the mesolimbic and nigrostriatal dopaminergic pathways | Q48182461 | ||
| Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain | Q48264084 | ||
| The influence of aripiprazole, olanzapine and enriched environment on depressant-like behavior, spatial memory dysfunction and hippocampal level of BDNF in prenatally stressed rats | Q48278774 | ||
| Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats | Q48318175 | ||
| The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole | Q48386935 | ||
| Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments | Q48544800 | ||
| DSP-4 prevents dopamine receptor priming by quinpirole. | Q48555410 | ||
| Acute amphetamine-induced subsensitivity of A10 dopamine autoreceptors in vitro | Q48669598 | ||
| Ontogenic homologous supersensitization of quinpirole-induced yawning in rats | Q48717336 | ||
| Neonatal 6-hydroxydopamine lesioning enhances quinpirole-induced vertical jumping in rats that were quinpirole primed during postnatal ontogeny | Q48943310 | ||
| Neonatal quinpirole treatment produces prepulse inhibition deficits in adult male and female rats. | Q50993302 | ||
| Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats. | Q52011150 | ||
| Stress and the progression of the developmental hypothesis of schizophrenia. | Q52112936 | ||
| Lifelong Rodent Model of Tardive Dyskinesia-Persistence After Antipsychotic Drug Withdrawal. | Q52147879 | ||
| Sex differences in dopamine receptors and their relevance to ADHD. | Q52171308 | ||
| Lack of association between the regulator of G-protein signaling 4 (RGS4) rs951436 polymorphism and schizophrenia. | Q55055346 | ||
| Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390 | Q63431049 | ||
| Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats | Q68083657 | ||
| Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA | Q68332298 | ||
| Stimulation of dopamine D2 receptors induces an analgesia involving an opioidergic but non enkephalinergic link | Q68492729 | ||
| Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats | Q69293036 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 183-192 | |
| P577 | publication date | 2015-11-07 | |
| P1433 | published in | Neurochemical Research | Q15716728 |
| P1476 | title | Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia | |
| P478 | volume | 41 |
| Q67874215 | Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders. |
| Q64123253 | Neuroreceptor kinetics in rats repeatedly exposed to quinpirole as a model for OCD |
| Q38726690 | Neuroteratology and Animal Modeling of Brain Disorders |
| Q89482331 | Simultaneous voltammetric determination of acetaminophen and dopamine using a glassy carbon electrode modified with copper porphyrin-exfoliated graphene |
Search more.